ATI - Advanced Medical Technologies

Company Overview

Snapshot

Founded in March 2005 by Tomas Mendelsohn, Abraham Livne, and Ilan Ron, ATI - Advanced Medical Technologies operates with 1–10 employees. The company focuses on developing medical devices for the ophthalmology market, with its flagship product, Field-Induced Mydriasis (FIM), a CE-approved pupil-dilation device, already released.

Business overview

ATI - Advanced Medical Technologies develops medical devices for the ophthalmology market, aiming to improve patient experience during diagnostic procedures and increase efficiency. Its core product, Field-Induced Mydriasis (FIM), is a non-contact, drug-free pupil-dilation device that achieves rapid dilation and recovery. The company is also developing NIT, a personal ocular tonometer for early glaucoma detection. ATI operates within the Health Tech & Life Sciences sector, specifically in Medical Devices and Diagnostics Devices, serving clinics and patients in markets such as China.

Company Intelligence Q&A

What is ATI - Advanced Medical Technologies' primary focus?

ATI - Advanced Medical Technologies specializes in developing medical devices for the ophthalmology market, with a focus on improving diagnostic procedures and patient experience.

Who founded ATI - Advanced Medical Technologies?

ATI - Advanced Medical Technologies was founded by Tomas Mendelsohn, Abraham Livne, and Ilan Ron in March 2005.

What is the Field-Induced Mydriasis (FIM) device?

FIM is ATI - Advanced Medical Technologies' flagship pupil-dilation device. It is a safe, non-contact, and drug-free device designed to achieve full dilation within 90 to 120 seconds, with rapid recovery.

What new product is ATI - Advanced Medical Technologies developing?

ATI - Advanced Medical Technologies is currently developing NIT, a personal ocular tonometer intended for use by patients to measure intraocular pressure for the early detection of glaucoma.

In which markets does ATI - Advanced Medical Technologies operate?

ATI - Advanced Medical Technologies targets various markets, including China, with its medical devices for ophthalmology.